Melanoma-associated antigen C1 (137-149)

Melanoma-associated antigen C1 (137-149) is a synthetic peptide fragment derived from the MAGE-C1 protein, a member of the melanoma-associated antigen gene family frequently expressed in various malignancies, particularly melanoma. As a defined peptide epitope corresponding to amino acids 137 through 149 of the parent protein, it serves as a highly relevant research tool for immunological studies, antigen processing investigations, and the development of peptide-based assays. Its sequence specificity and immunological relevance make it a valuable resource for elucidating mechanisms of immune recognition, antigen presentation, and tumor immunology, thereby supporting advanced research into tumor-associated antigens and their functional roles in cellular processes.

Epitope mapping: The peptide fragment is widely utilized in epitope mapping studies to identify and characterize T-cell or antibody recognition sites within the MAGE-C1 protein. By incorporating this defined sequence into immunological assays, researchers can investigate the specificity and breadth of immune responses directed against tumor-associated antigens. Such mapping is critical for understanding immune surveillance mechanisms and for the identification of immunodominant regions that may be relevant for further functional or translational research.

Immunogenicity assessment: Researchers employ the 137-149 peptide in ex vivo and in vitro assays to evaluate its capacity to stimulate T-cell responses, particularly in the context of antigen-presenting cell processing and MHC class I or II presentation pathways. These studies contribute to a deeper understanding of the immunogenic potential of specific tumor antigens, providing valuable insights into the cellular immune responses that may be elicited by naturally processed or synthetic peptides derived from melanoma-associated proteins.

Assay development: The defined peptide sequence is frequently used as a standard or control in the development and optimization of immunological assays, such as ELISPOT, flow cytometry-based tetramer staining, and peptide-MHC binding assays. By serving as a well-characterized antigenic target, the peptide enables the calibration and validation of experimental systems designed to detect antigen-specific T cells or antibodies, thereby enhancing the reliability and reproducibility of immunological measurements.

Antigen processing studies: Investigations into the intracellular processing and presentation of tumor antigens often utilize synthetic peptide fragments to dissect the pathways involved in MHC loading and antigen display. The 137-149 region of MAGE-C1 provides a model substrate for exploring the efficiency and specificity of proteasomal cleavage, transporter associated with antigen processing (TAP) translocation, and subsequent presentation by major histocompatibility complex molecules. Such studies are fundamental to understanding the molecular determinants of antigenicity and immune recognition in the context of cancer biology.

Peptide-based screening: The sequence-specific nature of this peptide allows for its incorporation into high-throughput screening platforms aimed at identifying T-cell receptors, antibodies, or small molecules that specifically interact with MAGE-C1-derived epitopes. These screening approaches support the discovery of novel immunological reagents, facilitate the characterization of antigen-antibody interactions, and enable the selection of candidates for further functional or mechanistic studies. By providing a defined and reproducible target, the peptide supports robust screening and discovery efforts in tumor immunology and related research fields.

1. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle

2. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

3. High fat diet and GLP-1 drugs induce pancreatic injury in mice

4. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes

5. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum